These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7297145)

  • 1. Effect of platelet suppressant treatment with dipyridamole and aspirin on exercise performance and platelet survival time in coronary disease.
    Steele P; Rainwater J; Vogel R
    Chest; 1981 Nov; 80(5):557-61. PubMed ID: 7297145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial of dipyridamole-aspirin in recurring venous thrombosis.
    Steele P
    Lancet; 1980 Dec 20-27; 2(8208-8209):1328-9. PubMed ID: 6109150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aspirin on exercise-induced angina.
    Davis JW; Lewis HD; Phillips PE; Schwegler RA; Yue KT; Hassanein KR
    Clin Pharmacol Ther; 1978 May; 23(5):505-10. PubMed ID: 346292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dipyridamole and low-dose aspirin therapy on platelet adhesion to vascular subendothelium.
    Lauri D; Zanetti A; Dejana E; de Gaetano G
    Am J Cardiol; 1986 Dec; 58(13):1261-4. PubMed ID: 3788816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time.
    Rajah SM; Penny AF; Crow MJ; Pepper MD; Watson DA
    Br J Clin Pharmacol; 1979 Nov; 8(5):483-9. PubMed ID: 508556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet tests and antiplatelet drugs in coronary artery disease.
    de Boer AC; Han P; Turpie AG; Butt R; Gent M; Genton E
    Circulation; 1983 Mar; 67(3):500-4. PubMed ID: 6217921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of acetysalicylic acid on changes in platelet function due to physical exertion.
    Rohrer TF; Pfister B; Imhof PR
    Arzneimittelforschung; 1977 Jul; 27(7):1490-3. PubMed ID: 578480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamole.
    Sinzinger H; O'Grady J; Fitscha P
    J Int Med Res; 1988; 16(1):39-43. PubMed ID: 3350203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of platelet deposition and thrombus formation on hemodialysis membranes: a double-blind randomized trial of aspirin and dipyridamole.
    Salter MC; Crow MJ; Donaldson DR; Roberts TG; Rajah SM; Davison AM
    Artif Organs; 1984 Feb; 8(1):57-61. PubMed ID: 6703927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dipyridamole and aspirin on shear-induced platelet aggregation in whole blood and platelet-rich plasma.
    Nakamura T; Uchiyama S; Yamazaki M; Iwata M
    Cerebrovasc Dis; 2002; 14(3-4):234-8. PubMed ID: 12403957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aspirin and dipyridamole on platelet function, hematology, and blood chemistry of saturation divers.
    Philp RB; Bennett PB; Andersen JC; Fields GN; McIntyre BA; Francey I; Briner W
    Undersea Biomed Res; 1979 Jun; 6(2):127-46. PubMed ID: 531993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of antiplatelet drugs in coronary heart disease.
    Mehta J; Mehta P
    JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet release reaction in vivo in patients with ischaemic heart disease after isometric exercise and its prevention with dipyridamole.
    Sano T; Motomiya T; Yamazaki H
    Thromb Haemost; 1980 Feb; 42(5):1589-97. PubMed ID: 6966082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers.
    Caplain H
    Cerebrovasc Dis; 2005; 19(4):214-9. PubMed ID: 15703464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dipyridamole and acetylsalicylic acid on platelet functions in patients with aortic ball-valve prostheses.
    Dale J; Myhre E; Rootwelt K
    Am Heart J; 1975 May; 89(5):613-8. PubMed ID: 1119369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipyridamole: a critical evaluation.
    Rivey MP; Alexander MR; Taylor JW
    Drug Intell Clin Pharm; 1984 Nov; 18(11):869-80. PubMed ID: 6389068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A trial of dipyridamole and aspirin in the prevention of smoking-induced changes in platelets and endothelium in men with coronary artery disease.
    Davis JW; Hartman CR; Shelton L; Ruttinger HA
    Am J Cardiol; 1989 Jun; 63(20):1450-4. PubMed ID: 2524959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.